{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:07:24Z","timestamp":1791022044667,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.bbrc.2012.02.121","type":"journal-article","created":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T10:12:44Z","timestamp":1330942364000},"page":"96-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The receptor for advanced glycation endproducts and its ligands in patients with myasthenia gravis"],"prefix":"10.1016","volume":"420","author":[{"given":"Bernhard","family":"Moser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bekos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"Zimprich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Nickl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Klepetko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Ankersmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2012.02.121_b0005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1196\/annals.1254.053","article-title":"The epidemiology of myasthenia gravis","volume":"998","author":"Phillips","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"10","key":"10.1016\/j.bbrc.2012.02.121_b0010","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","article-title":"Unravelling the pathogenesis of myasthenia gravis","volume":"2","author":"Vincent","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"21","key":"10.1016\/j.bbrc.2012.02.121_b0015","doi-asserted-by":"crossref","first-page":"14987","DOI":"10.1016\/S0021-9258(18)42137-0","article-title":"Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface","volume":"267","author":"Schmidt","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"6784","key":"10.1016\/j.bbrc.2012.02.121_b0020","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/35012626","article-title":"Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases","volume":"405","author":"Taguchi","year":"2000","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbrc.2012.02.121_b0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11926-008-0054-1","article-title":"The role of high-mobility group box 1 protein in the pathogenesis of autoimmune diseases","volume":"10","author":"Voll","year":"2008","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.bbrc.2012.02.121_b0030","doi-asserted-by":"crossref","unstructured":"U. Andersson, H.E. Harris, The role of HMGB1 in the pathogenesis of rheumatic disease, Biochim. Biophys. Acta 1799 (1\u20132) (2010) 141\u2013148 (Review).","DOI":"10.1016\/j.bbagrm.2009.11.003"},{"key":"10.1016\/j.bbrc.2012.02.121_b0035","first-page":"539581","article-title":"The S100B\/RAGE axis in Alzheimer\u2019s disease","volume":"2010","author":"Leclerc","year":"2010","journal-title":"Cardiovasc. Psychiatry Neurol."},{"key":"10.1016\/j.bbrc.2012.02.121_b0040","doi-asserted-by":"crossref","unstructured":"A.J. Halayko, S. Ghavami, S100A8\/A9: a mediator of severe asthma pathogenesis and morbidity? Can. J. Physiol. Pharmacol. 87 (10) (2009) 743\u2013755 (Review).","DOI":"10.1139\/Y09-054"},{"key":"10.1016\/j.bbrc.2012.02.121_b0045","doi-asserted-by":"crossref","unstructured":"B. Moser, B.I. Hudson, A.M. Schmidt, Soluble RAGE: a hot new biomarker for the hot joint? Arthritis Res Ther. 7 (4) (2005) 142\u2013144.","DOI":"10.1186\/ar1764"},{"issue":"17","key":"10.1016\/j.bbrc.2012.02.121_b0050","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.2741\/3884","article-title":"Alternative splicing of RAGE: roles in biology and disease","volume":"1","author":"Kalea","year":"2011","journal-title":"Front Biosci."},{"issue":"2","key":"10.1016\/j.bbrc.2012.02.121_b0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1600-6143.2006.01617.x","article-title":"Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation","volume":"7","author":"Moser","year":"2007","journal-title":"Am. J. Transplant."},{"issue":"12","key":"10.1016\/j.bbrc.2012.02.121_b0060","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.4049\/jimmunol.179.12.8051","article-title":"Receptor for advanced glycation end products expression on T cells contributes to antigen-specific cellular expansion in vivo","volume":"179","author":"Moser","year":"2007","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.bbrc.2012.02.121_b0065","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.4049\/jimmunol.173.2.1399","article-title":"Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products","volume":"173","author":"Chen","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrc.2012.02.121_b0070","doi-asserted-by":"crossref","first-page":"R817","DOI":"10.1186\/ar1749","article-title":"Decreased levels of soluble receptor for advanced glycation endproducts in patients with rheumatoid arthritis indicating deficient inflammatory control","volume":"7","author":"Pullerits","year":"2005","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.bbrc.2012.02.121_b0075","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00296-010-1636-6","article-title":"Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-alpha and TNF-alpha in systemic lupus erythematosus","volume":"32","author":"Ma","year":"2012","journal-title":"Rheumatol. Int."},{"issue":"4","key":"10.1016\/j.bbrc.2012.02.121_b0080","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2796.2011.02432.x","article-title":"High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus","volume":"270","author":"Urbonaviciute","year":"2011","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbrc.2012.02.121_b0085","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1016\/S0021-9258(19)89188-3","article-title":"Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein","volume":"261","author":"Ahmed","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2012.02.121_b0090","first-page":"138","article-title":"Pathogenetic effects of advanced glucosylation: biochemical, biologic and clinical implications for diabetes and aging","volume":"70","author":"Vlassara","year":"1994","journal-title":"Lab. Invest."},{"issue":"3","key":"10.1016\/j.bbrc.2012.02.121_b0095","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1194\/jlr.M200370-JLR200","article-title":"Autoimmune response to advanced glycosylation end-products of human LDL","volume":"44","author":"Virella","year":"2003","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.bbrc.2012.02.121_b0100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nm831","article-title":"Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system","volume":"9","author":"Yan","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2012.02.121_b0105","doi-asserted-by":"crossref","unstructured":"D. Foell, H. Wittkowski, T. Vogl, et al., S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules, J. Leukoc. Biol. 81 (1) (2007) 28\u201337 (Review).","DOI":"10.1189\/jlb.0306170"},{"key":"10.1016\/j.bbrc.2012.02.121_b0110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.clim.2011.04.013","article-title":"Activation of the receptor for advanced glycation end products (RAGE) exacerbates experimental autoimmune myasthenia gravis symptoms","volume":"141","author":"Mu","year":"2011","journal-title":"Clin. Immunol."},{"issue":"12","key":"10.1016\/j.bbrc.2012.02.121_b0115","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.2337\/diabetes.50.12.2792","article-title":"Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB","volume":"50","author":"Bierhaus","year":"2001","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.bbrc.2012.02.121_b0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archneur.56.1.25","article-title":"Late-onset myasthenia gravis: a changing scene","volume":"56","author":"Aarli","year":"1999","journal-title":"Arch. Neurol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X12003804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X12003804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:00:33Z","timestamp":1757761233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X12003804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0006291X12003804"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2012.02.121","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The receptor for advanced glycation endproducts and its ligands in patients with myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2012.02.121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}